What Changed at AZmed

Every material change AI Health Index has tracked at AZmed: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact

Type

1 entry

Showing changes for AZmed only.Show the full log

September 2026

A

AZmed

Sep 15, 2026

HighVerified

Regulatory / FDA

AZmed received its sixth FDA clearance, for AZchest to detect and localize pneumothorax and pleural effusion on chest radiographs. That brings its Rayvolve suite to eight FDA cleared findings, and AZchest can now flag up to five findings on a single chest image.

Our read

Pneumothorax is a time critical miss, which is why this clearance matters more than the count. AZmed cites reading time reductions of up to 31 percent for readers outside thoracic radiology; that is the group to test it with, since specialist readers gain least.

Related axis: FDA and Regulatory StatusVendor announcementView source